会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • TREATMENT OF NEUROTROPHIC FACTOR MEDIATED DISORDERS
    • 治疗神经介导因子介导性疾病
    • WO2010084356A1
    • 2010-07-29
    • PCT/GB2010/050098
    • 2010-01-22
    • PHYTOPHARM PLCREES, DarylORSI, AntoniaHOWSON, PatrickXIA, ZongqinHU, Yaer
    • REES, DarylORSI, AntoniaHOWSON, PatrickXIA, ZongqinHU, Yaer
    • A61K31/58A61P17/02A61P17/16A61P17/18A61P25/00A61P37/00
    • A61K31/58A61K31/7048
    • An agent selected from A/B-cis furostane, furostene, spirostane and spirostene steroidal sapogenins and ester, ether, ketone and glycosylated forms thereof is used to induce self- regulated homeostasis of neurotrophic factors(NFs), for example BDNF and/or GDNF, NFs with limited and manageable side effects in a subject, by modulating NFs in a non- toxic manner under homeostatic control. An effective amount of at least one such agent is administered to the subject, particularly in the treatment or prevention of a range of NF- mediated disorders, particularly neurological, psychiatric, inflammatory,allergic,immune and neoplastic disorders, and in the restoration or normalisation of neuronal and other function in or in relation to any damaged or abnormal tissue, including when assisting tissue (for example, skin, bone, eye and muscle) healing and general skin, bone, eye and muscle health.
    • 使用选自A / B-顺式呋喃斯坦,呋喃葡萄烯,螺甾烷和螺甾烷基甾体皂苷元及其酯,醚,酮及其糖基化形式的药剂诱导神经营养因子(NF)的自我调节的体内平衡,例如BDNF和/或GDNF 通过在稳态控制下以非毒性方式调节NFs,在受试者中具有有限和易于治疗的副作用的NF。 向受试者施用有效量的至少一种这样的药剂,特别是在治疗或预防一系列NF介导的病症,特别是神经,精神,炎症,过敏,免疫和肿瘤性疾病中,以及在恢复或正常化中 包括当辅助组织(例如皮肤,骨骼,眼睛和肌肉)愈合和一般皮肤,骨骼,眼睛和肌肉健康时,神经元和其他功能在任何损伤或异常组织中或与之相关。